Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review
Author:
Funder
Novartis Pharma
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference46 articles.
1. Angiotensin–neprilysin inhibition versus enalapril in heart failure;McMurray;N. Engl. J. Med.,2014
2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
3. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
4. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology;Seferovic;Eur. J. Heart Fail.,2019
5. 2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee;Hollenberg;J. Am. Coll. Cardiol.,2019
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction;Frontiers in Cardiovascular Medicine;2024-05-10
2. Application of eligibility criteria from DAPA-HF, EMPEROR-Reduced, and PARADIGM-HF trials to a population with heart failure with reduced ejection fraction at a specialized cardiology Clinic in Medellin, Colombia: A retrospective cohort study;Current Problems in Cardiology;2024-02
3. The neuroprotective effect of LCZ696 on methamphetamine-induced cognitive impairment in mice;Neuroscience Letters;2024-02
4. The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data;International Journal of Cardiology;2024-02
5. Real-world analysis of integration of sacubitril/valsartan into clinical practice in Saudi Arabia;Medicine;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3